Lymphocyte-Activation Gene 3 (LAG3) (C-Term) Peptide
Quick Overview for Lymphocyte-Activation Gene 3 (LAG3) (C-Term) Peptide (ABIN8104630)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Purpose
- LAG3 Peptide - C-terminal region
-
Sequence
- GFHLWRRQWR PRRFSALEQG IHPPQAQSKI EELEQEPEPE PEPEPEPEPE
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-LAG3 Antibody(ARP59142_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
-
Background
-
Background Information: Lymphocyte-activation protein 3 belongs to Ig superfamily and contains 4 extracellular Ig-like domains. The LAG3 gene contains 8 exons. The sequence data, exon/intron organization, and chromosomal localization all indicate a close relationship of LAG3 to CD4.
Alternative Symbols: CD223
-
Molecular Weight
- 55kDa
-
Gene ID
- 3902
-
NCBI Accession
- NP_002277
-
UniProt
- P18627
Target
-